Aurinia Pharmaceuticals Inc. (AUPH) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.11B, a trailing price-to-earnings ratio of 6.9 and a free-cash-flow yield of 6.2%. Over the most recent reported fiscal year, revenue grew 20.4% and free cash flow per share grew 223.6%.